Drug Target Review

JULY 31, 2023

Prior to UCSF, Michelle was Associate Director of cell biology at Sunesis Pharmaceuticals, where she helped discover inhibitors of protein-protein interactions for IL-2/IL-2R and LFA1/ICAM (lifitegrast, marketed by Novartis).

DNA 98

DNA Small Molecule Science Cell Biology 98

Drug Target Review

MAY 21, 2024

Ending up at a small start-up, which has since become Molecular Devices, I took on the challenge of commercialising new technology in an underdeveloped market. I don’t think that it’s harder for women to enter careers in STEM, at least not in the scientific field—cell biology—that I have predominantly worked in.

Doctors 59

Doctors Science Research Cell Biology 59

The Pharma Data

JANUARY 4, 2021

Innate has been a pioneer in the understanding of natural killer cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering.

Drugs 40

Drugs Cell Biology Pharmacokinetics Clinical Trials 40

The Pharma Data

OCTOBER 22, 2020

Innate has been a pioneer in the understanding of natural killer cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering.

Clinical Trials 40

Clinical Trials Trials Cell Biology Production 40

Codon

APRIL 9, 2024

Delays In the early 1980s, eager to push artemisinin onto the international market, China turned to the World Health Organization (WHO). When Louis Miller, now Chief of Malaria Cell Biology at the NIH, attended a malaria conference in Shanghai in 2008, he asked: Who discovered artemisinin? Nobody had an answer.

Drugs 140

Drugs Science Research Doctors 140

The Pharma Data

MARCH 16, 2022

The research scientist at the Max Planck Institute for Medical Research received the award in recognition of his ground-breaking work in establishing various approaches to protein labeling in living cells that have enabled far-reaching advances in chemical and cell biology. Protein labeling (e.g.

Cell Biology 52

Cell Biology Molecular Biology Science Laboratories 52

Drug Target Review

JUNE 29, 2023

It’s great that we are in clinical trials, and we are helping a certain number of patients, but if you don’t make it to the market and all that involves, then you haven’t really won because you think of all those patients that you’re no longer serving if you don’t get to that end goal.

Therapies 115

Therapies Science Production Cell Biology 115

The Pharma Data

MARCH 11, 2021

Speaking at the virtual Capital Markets Day on Wednesday, CEO Werner Baumann emphasized Bayer’s long-term growth perspectives: “Bayer is a leading life science company, uniquely positioned at the intersection of health and nutrition – with attractive prospects for growth, earnings and cash flow.” In addition to further strengthening its U.S.

Science 52

Science Pharmaceuticals Licensing Licensing 52

Drug Target Review

DECEMBER 21, 2023

Where do you see the future of mRNA biology and AI converging, and how does Anima Biotech plan to lead this convergence? mRNA biology has become widely recognised as a new “drug mine” RNAi drugs are in the market and mRNA vaccines, initially developed for Covid-19, are already in trials for cancer.

Disease 105

Disease Small Molecule Vaccine Drugs 105

Codon

APRIL 30, 2023

5/ Lots O’ Gene Therapies Not one, but two applications for sickle-cell gene therapies have been submitted to the F.D.A. If approved, these wouldn’t be the first gene therapies on the market, but they would be the first gene therapies for a disease that affects something like 100,000 Americans. Nature Cell Biology.

Vaccine 52

Vaccine DNA Engineering RNA 52

Codon

APRIL 30, 2023

5/ Lots O’ Gene Therapies Not one, but two applications for sickle-cell gene therapies have been submitted to the F.D.A. If approved, these wouldn’t be the first gene therapies on the market, but they would be the first gene therapies for a disease that affects something like 100,000 Americans. Nature Cell Biology.

Vaccine 52

Vaccine DNA Engineering RNA 52

Codon

APRIL 9, 2023

Nature Cell Biology. Now, regulators are trying to figure out how to bring phage therapies — viruses engineered to target and kill specific bacteria that cause, say, an antibiotic-resistant infection — to market. Trends in Biotechnology. Read Julia for biologists. Nature Methods. Science Advances.

Therapies 52

Therapies RNA Engineering Vaccine 52

Drug Target Review

APRIL 1, 2025

I then took over management of a research group, initially running cell biology research and then preclinical development.” The market for antisense oligonucleotides (ASOs), a form of gene silencing, was valued at $4.4 . “I have been in the industry for over 20 years,” Williams explains. billion by 2032.

Disease 52

Disease Therapies Clinical Trials Cell Biology 52

Drug Target Review

MARCH 26, 2025

4 Shortly after, testosterone pellets hit the market, followed by injectable ester forms. She has a background in cell biology, biophysics and pharmacology and was a professor and Chair at the University of Kansas for over 20 years. In 1935, testosterone was chemically synthesised, representing a major milestone in the field.

Therapies 52

Therapies Compliance Treatment Small Molecule 52

Codon

NOVEMBER 1, 2024

Molecular biology has only been around for about 80 years, and tools to study biomolecules (such as DNA and RNA sequencing, or proteomics) have only existed for about half of that time. We are in the absolute infancy of molecular and cell biology, and this means there’s a lot of stuff we still don’t understand.

DNA 128

DNA RNA Molecular Biology Laboratories 128